NCT01407289View on ClinicalTrials.gov

A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Aspart, Insulin Glargine

The Intervention is a paper based protocol, which provides suggestions for new insulin doses (basal-bolus regime).

Trial Locations (1)

8036

Medical University of Graz, Division of Internal Medicine, Department of Endocrinology and Metabolism/ Cardiology, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT01407289 - A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia | Biotech Hunter | Biotech Hunter